跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EQ-6
首页
药物
EQ-6
EQ-6
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Mutated immunoglobulin-binding polypeptides
CN 118546242 A
申请人: GE HEALTHCARE BIOPROCESS R&D AB
优先权: 2014
CN
4 件公开
[1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT
EP 4727944 A1
申请人: PERHA PHARMACEUTICALS
优先权: 2023
EP
2 件公开
SiRNA of targeted FASN gene, carrier compound and application of siRNA and carrier compound
CN 118256500 A
申请人: UNIV PEKING 3RD HOSPITAL PEKING UNIV 3RD CLINICAL MEDICAL COLLEGE
优先权: 2024
CN
2 件公开
Dihalo-allyloxy-phenol derivatives having pesticidal activity
US 2006014806 A1
申请人: ZAMBACH WERNER
优先权: 2002
US
Antigens Targeted by Prevalent Pathogennic T Cells in Type 1 Diabetes and Uses Thereof
US 2008153112 A1
申请人: DILORENZO TERESA P
优先权: 2004
US
Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
US 2005031523 A1
申请人: WONG RAYMOND J
优先权: 2004
US
Process for synthesizing 6-(trifluoromethyl)pyridine-3-carboxaldehyde
CN 105622491 A
申请人: ZHAO JIANYING
优先权: 2014
CN
Synthetic process of 6-(trifluoromethyl)pyridine-3-carboxaldehyde
CN 105566208 A
申请人: QINGDAO SHOUTAI AGRICULTURAL SCIENCE & TECH CO LTD
优先权: 2014
CN
Processes for preparing an FGFR inhibitor
US 10538518 B2
申请人: PRINCIPIA BIOPHARMA INC
优先权: 2016
US
Clean production method of antitumor drug pelitinib intermediate
CN 108675958 A
申请人: SUN JINXIA
优先权: 2018
CN
第 1 / 2 页
上一页
下一页
药物
反馈